Chemcon Speciality Chemicals Ltd
Chemcon Speciality Chemicals Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Chemcon Speciality Chemicals Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q1 FY27 Revenue from Operations: Rs. Quarterly EBITDA: ₹15.4 Cr (Q1 FY27), up 98% YoY from ₹7.7 Cr (Q1 FY26) - Operating (EBITDA) Margin: 23.2% (Q1 FY27) vs 14.5% (Q1 FY26) - Profit After Tax (PAT): ₹11.0 Cr (Q1 FY27), up 7
From Chemcon Speciality Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1 FY27 Revenue from Operations: Rs. 66.5 Cr, up 24% YoY from Rs. 53.5 Cr in Q1 FY26 (Page 7).
- Q1 FY27 Sales Volume: Total 3,302 MT (Organic Chemicals: 2,066 MT; Inorganic Chemicals: 1,236 MT) (Page 6).
- Q1 FY26 Sales Volume: Total 3,434 MT (Organic Chemicals: 2,098 MT; Inorganic Chemicals: 1,336 MT), indicating a slight volume decline YoY (Page 6).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Plan to add manufacturing capacity at the P11 unit dedicated to organic chemicals (Page 19, 17).
- Capacity expansion aims to manufacture organic chemicals such as HMDS, CMIC, Bromobenzene, 2 Bromo (Page 17).
- No specific capex amounts mentioned for P11 unit expansion.
- Timeline for new product launches: Bromobenzene business commenced in 2023, 2-Bromo business started in 2025 (Page 13).
- FY22–24 period saw acquisition of Shivam Petrochem Industries and increased capacity via commissioning plants P7, P8, and P9 (Page 10).
- FY25 timeline lists first sale of new chemical products like Pyridine Hydrobromide, Para Nitro Benzyl Bromide, Methyl Iodide, GA-1 (Page 10).
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemcon Speciality Chemicals Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q2 FY24 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q1 FY22 earnings call →
- Q4 FY21 earnings call →
Others in Chemicals & Petrochemicals this season
- Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
- Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…
- Chemfab Alkalis Ltd (Q1 FY27)
Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key concall takeaways from Chemfab Alkalis Ltd's Q1…
Frequently Asked Questions
What were Chemcon Speciality Chemicals Ltd Q1 FY27 results?
Q1 FY27 Revenue from Operations: Rs. Quarterly EBITDA: ₹15.4 Cr (Q1 FY27), up 98% YoY from ₹7.7 Cr (Q1 FY26) - Operating (EBITDA) Margin: 23.2% (Q1 FY27) vs 14.5% (Q1 FY26) - Profit After Tax (PAT): ₹11.0 Cr (Q1 FY27), up 7
What is Chemcon Speciality Chemicals Ltd share price analysis?
Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemcon Speciality Chemicals Ltd planning capital expenditure?
Plan to add manufacturing capacity at the P11 unit dedicated to organic chemicals (Page 19, 17).
Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.